Skip to main content
Atrás
Watch Compare

ASSEMBLY BIOSCIENCES, INC.

Calidad de datos: 100%
ASMB
Nasdaq Manufacturing Chemicals
$29.87
▲ $0.52 (1.77%)
Cap. Mercado: 473.82 M
Precio
$29.87
Cap. Mercado
473.82 M
Rango del Día
$29.10 — $30.18
Rango de 52 Semanas
$7.90 — $39.71
Volumen
76,400
Apertura $29.10
Promedio 50D / 200D
$28.04
6.55% above
Promedio 50D / 200D
$27.16
9.98% above

Quick Summary

Puntos Clave

Negative free cash flow of -41.16 M
Capital efficient — spends only 0.09% of revenue on capex

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-6.10%
Above sector avg (-51.02%)
ROIC-8.70%
Net Margin-8.47%
Op. Margin-16.76%

Seguridad

Debt / Equity
N/A
Current Ratio4.44
Interest CoverageN/A

Valoración

PE (TTM)
-77.40
Below sector avg (-1.98)
P/B Ratio2.59
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (44 pares)
Métrica Acción Mediana del Sector
P/E -77.4 -2.0
P/B 2.6 5.1
ROE % -6.1 -51.0
Net Margin % -8.5 -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 72.30 M Net Income (TTM) -6.12 M
ROE -6.10% ROA -3.82%
Gross Margin N/A Operating Margin -16.76%
Net Margin -8.47% Free Cash Flow (TTM) -41.16 M
ROIC -8.70% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.44
Interest Coverage N/A Asset Turnover 0.45
Working Capital 183.43 M Tangible Book Value 182.70 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -77.40 Forward P/E N/A
P/B Ratio 2.59 P/S Ratio 6.55
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8.69%
Market Cap 473.82 M Enterprise Value 451.29 M
Per Share
EPS (Diluted TTM) -0.55 Revenue / Share 4.56
FCF / Share -2.59 OCF / Share -2.59
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.09% FCF Conversion 672.31%
SBC-Adj. FCF -45.17 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 72.30 M — — — —
Net Income -6.12 M -40.18 M -61.23 M -93.09 M -129.86 M
EPS (Diluted) -0.55 -6.69 -13.38 -1.92 —
Gross Profit — — — — —
Operating Income -12.12 M -45.42 M -64.65 M -94.11 M -132.69 M
EBITDA — — — — —
R&D Expenses 64.81 M 55.93 M 48.90 M 69.98 M 68.52 M
SG&A Expenses — — — — —
D&A 129,000.0 129,000.0 450,000.0 498,000.0 466,000.0
Interest Expense — — — — —
Income Tax 0.0 330,000.0 33,000.0 0.0 -2.53 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 257.59 M 119.17 M 136.82 M 101.79 M 191.06 M
Total Liabilities 50.84 M 85.81 M 95.73 M 19.13 M 22.13 M
Shareholders' Equity 206.75 M 33.36 M 41.10 M 82.66 M 168.93 M
Total Debt — — — — —
Cash & Equivalents 58.45 M 38.34 M 19.84 M 52.42 M 45.63 M
Current Assets 254.55 M 115.50 M 133.79 M 96.97 M 154.20 M
Current Liabilities 48.78 M 47.80 M 39.23 M 16.30 M 16.07 M